Summary.-Maturation of monocytes into macrophages in vitro has been assayed by a quantitative microtitre assay in patients with squamous-cell carcinoma of the lung. Monocyte maturation in autologous serum was significantly depressed in patients with both limited and extensive disease compared with normal controls, patients with chronic obstructive airways disease and controls matched for age, sex, smoking history, respiratory function and the presence of infection. Maturation of monocytes from patients with terminal non-malignant disease was depressed, though not to the same extent as in those with extensive malignancy. Monocytes from relatives of patients with squamous-cell carcinoma of the lung matured normally.
In 10 patients with limited disease, in vitro monocyte maturation was repeated 6-12 weeks after operation, and was found to relate to prognosis.
THE FIRST SUGGESTION that macrophages might participate as effectors in tumour-cell destruction was made by Gorer (1961) on the basis of morphological studies of ascitic tumours in mice. Since that time there has been increasing evidence that cells of the mononuclear phagocyte system (MPS) may be important in natural surveillance against malignant cells. Nude mice, devoid of a T-lymphocyte system, do not have an increased frequency of all spontaneous tumours, as would be anticipated if an immunological surveillance mechanism were based on the T cell (Outzen et al., 1975) . In fact, the incidence of tumours is diminished, which could be explained if the macrophage were the important antitumour effector cell, since macrophage function is "activated" in these animals (Cheers & Waller, 1975) .
The resistance of animals to challenge with tumours may be influenced by altering the function of the MPS in vivo (Tevethia et al., 1976; Isa & Sanders, 1975) . Macrophages from animals treated with MPS activators can be shown to possess the potential for tumour-cell cytotoxicity (Hibbs, 1976) , as can the macrophages extracted from animal tumours (Holden et al., 1976) . Recent work has extended these findings to human monocytes and macrophages (Mantovani et al., 1979) and to macrophages isolated from human tumours (Vose, 1978) . Macrophages are often present in considerable numbers within tumours (Evans, 1972) and in some cases their number has been inversely related to the metastatic potential of the tumour (Lauder et al., 1977) .
As a result of this work suggesting importance of the MPS in defence against malignancy, there has been considerable interest in the function of cells of this system in tumour-bearing hosts. The absolute number of peripheral-blood monocytes is normal or increased (Barrett 1970) , as is their number as a proportion of all mononuclear cells (Rhodes, 1977a) . Metabolic activity (King et al., 1977) , in vivo phagocytic capacity (Margarey & Baum, 1977) and Fc-receptor expression (Rhodes, 1 977b) are increased but, conversely, migration in vivo (Dizon & Southam, 1963) and in vitro (Snyderman et al., 1977) is decreased. Monocyte production from marrow in animals is increased (Meuret et al., 1977) but recent reports suggest that the ability of monocytes to mature into macrophages in vitro is reduced (Currie & Hedley, 1977; Taylor & Currie, 1979) . This lack of ability to mature has been shown to be related to prognosis in primary breast cancer (Taylor & Currie, 1979) and to be restored by treatment with Corynebacteriurn parvurn in patients with malignant melanoma (Hedley et al., 1979) .
The aim of this study was to quantitate in vitro maturation of monocytes from patients with squamous-cell carcinoma (SCC) of the lung and from controls (normal volunteers and patients with nonmalignant disease). In addition, the effect of severe debility has been investigated and a group of first-degree relatives studied. Classification of the tumours as squamous was based on cytological examination of the sputum (12 patients), histology of biopsy material (25) and resection specimens (3). All patients were considered to have definite SCC, the specimens showing keratinization and, in the majority, intercellular bridges (Kreyberg et al., 1967) . A number of patients were taking bronchodilator therapy, and a few were being treated with antibiotics for clinically diagnosed episodes of infection. Forty patients were studied:
PATIENTS, MATERIALS AND METHODS

Patients
Group 1-20 with limited disease Group 2-20 patients with extensive disease Control Groups 113 control subjects were assessed and these w%Aere divided into the following groups:
Group 3 10 normal non-smokers, aged Group 9-10 relatives of patients with SCC of the lung. First-degree relatives, siblings and children of the index patients were studied. They were all healthy at the time of the study and receiving no drug therapy.
Group 10-10 patients were re-studied after surgical resection of their primary tumour. They were investigated no sooner than 6 weeks, and no later than 12 weeks after their operation.
Groups 11 and 12-In addition, each patient with cancer was compared with a subject from one of the control groups, matched for sex, age (within the same decade), respiratory function ( < 50%, 50-75%, > 75% of predicted; Cotes, 1975) , forced expiratory volume (FEV1) or forced vital capacity (FVC), whichever was least, as assessed by dry spirometry (vitalograph), smoking habit (present smoker, ex-smoker for more than 6 months, non-smoker) and the presence of infection. Clinical details of all patients and controls are summarized in Table I .
Monocyte maturation.-This was based on the assay described by Currie & Hedley (1977) . Blood was drawn between 08:30 and 11:00 and the sample divided into 2. The first 30 ml was allowed to clot in sterile plastic universals and the serum separated. Any serum not used the same day was stored at -70°C in lml aliquots. The Fifty microlitres of cell suspension and 50 ,l of serum were added to the wNells of microtitre plates (Nunclon Delta, Denmark) and incubated at 37°C in a humidified atmosphere of 50o CO2 in air. Cytospin preparations (Shandon Southern) were made of the same cell suspensions for histochemical staining. These were fixed with cold buffered formol acetone for 15 sec, air-dried and stained for nonspecific esterase activity (NSE) at pH 6-3, as described by Yam et al. (1970) .
From these preparations. counts of the percentage monocytes were made, a total of 300 cells being counted in each case.
At 7 days each well was washed x 3 with RPMI 1640 to remove non-adherent cells and the nuclei of the remaining adherent cells were released and stained by adding 50 ,ul of 0-lM citric acid containing 1:2000 crystal violet (Sanford et al., 1951 In a series of 6 patients with SCC and 4 normal controls, adherence at 2 h was measured in parallel with a determination of monocyte maturation at Day 7 (Table  II) . Although cell adherence at 2 h was reduced in some SCC patients, there was no consistent correlation with depressed monocyte maturation at Day 7.
Variability of results
The well-to-well variation in results was small, the coefficients of variation of 10 replicate wells being 8.5% 7-0% and 4.0% in 3 separate sets of cells. The effect of passage of time on results was assessed by measuring the monocyte maturation of one normal control on 20 separate occasions over 3 months. The mean result was 54-8%, with a standard deviation of 6.5% and coefficient of variation 18.0%. Every patient and every control subject in Groups 1-6 was tested on 2 separate occasions within 3 days of each other. The mean difference in percent maturation between the two occasions was 4.4 + 3.10% for the SCC patients and 5*0 +3-8% for the normal controls.
Monocyte maturation in autologous serum
A total of 93 controls and 40 SCC patients has been studied. The results of monocyte maturation in Control Groups 3-7 are given in Table III . There was no significant difference that could be attributed to age (Groups 3 & 4), cigarette smoking (Groups 2 & 3) or infection (Groups 6 & 7). There was no significant difference between monocyte maturation in males or females within Groups 3-7, nor any difference between patients suffering from COAD with normal or abnormal respiratory function. For the purposes of further comparison with patients and other control groups the results of all normal controls (Groups 3-5) and all than in limited disease (P < 0.01). The size of the primary tumour was available in 32/40 SCC patients, either from the chest radiograph or measurement of the surgically removed specimen. An analysis of these patients revealed no correlation between the size of the primary tumour and monocyte maturation. The effect of debility was assessed in two ways. First, the level of serum albumin in SCC patients was compared with the result of in vitro monocyte maturation; no correlation was found. Second, 10 patients with serious terminal non-malignant disease (Group 8) were studied (Table IV) . Mean maturation in this group was 19.2%, which was significantly lower than in normal controls (P < 0.001.) but very similar to that in the group of patients with limited malignancy. Patients with extensive SCC had lower maturation (14-2%) than those with terminal non-malignant disease (19.20°). 
DISCUSSION
The maturation of monocytes into macrophages in vitro has been studied for many years (Lewis, 1925) and there is general agreement that in vivo maturation of monocytes provides a sizeable proportion of tissuie macrophages (Volkman, 1970) . Culture of both animal and human monocytes has been used as a source of macrophlages suitable for in vitiro functional studies (Blaese, 1972 In this study, normal control monocytes matured in a mean percentage of 44*9 + 6*5, which compares with the normal result (48.3 +±197) in the paper of Taylor & Currie (I1979). The reason for the reduced spread of the resuilts in ouir study is unclear. Ouir results also agree with previous w-ork, in finding no effect of age, sex or cigarette smoking on maturation (Currie & Hedley, 1977 (Currie & Hedley, 1977) and with breast carcinoma (Taylor & Currie, 1979) . The deficit was more pronounced in those with extensive disease, only 3/20 such patients having values within the range in normal controls, compared with 8/20 with limited disease. This is in keeping with the findings of others (Currie & Hedley, 1977; Taylor & Currie, 1979 ) that the defect of maturation is quantitatively related to tumour burden. It is too early to comment in any depth on the correlation of monocyte maturation with clinical prognosis, but in respect to the effects of surgery it is perhaps worth noting that of the 2 subjects in whom postoperative maturation was very low, one died after 5 months and the other developed hepatic metastases after 6 months. The other 8 subjects studied longitudinally after surgery remained well at least 6 months later, and this includes 3 patients in whom pre-operative monocyte maturation was depressed but returned to normal after resection. One patient who received intrapleural BCG as an adjunct to surgery showed a dramatic increase in maturation from 5% preoperatively to 31.5% 2 months postoperatively. This is of particular interest in view of the dramatic increases in monocyte maturation noted in patients with malignant melanoma after C. parvum treatment (Hedley et al., 1979) . The correlation of depression of monocyte maturation with extent of disease raises the question whether increasing metabolic disturbance and general debility underlie the abnormality. Such disturbances may be associated with abnormalities of immune function (Smythe et al., 1971; Law et al., 1973) and macrophage killing of micro-organisms (Olson et al., 1978) . However, although this may be partly the cause it is unlikely to be the sole explanation. The group of 10 patients with terminal non-malignant disease was chosen deliberately to represent subjects with severe debility. Their levels of serum albumin were lower than those of the group of patients with extensive malignant disease (Table III) , but the latter group showed more depression of monocyte maturation than the former. Within the group of patients with limited and extensive SCC there was no correlation of monocyte maturation with serum albumin level. Furthermore, patients with malignancy were tested at the time of their initial investigation and diagnosis, when they were not severely debilitated.
The possibility that some subjects may be more likely to develop malignancy due to an inherited deficiency of monocyte/ macrophage natural surveillance is attractive but we have been unable to show that first-degree relatives of patients with SCC were in any way different from control subjects. Although the number of patients studied was insufficient to exclude genetic influence, the relation of depressed maturation to extent and size of tumour suggests that the defect is secondary to the development of the malignancy. (Maderazo et al., 1978; Kjeldsberg & Pay, 1978) , and serum from cancer patients may alter monocyte Fc receptor expression (Rhodes et al., 1979) and inhibit granulocyte-macrophage colonv formation (Liu et al., 1979 
